0001661539-22-000005.txt : 20220203 0001661539-22-000005.hdr.sgml : 20220203 20220203173641 ACCESSION NUMBER: 0001661539-22-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trevejo Jose M. CENTRAL INDEX KEY: 0001661539 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39614 FILM NUMBER: 22589898 MAIL ADDRESS: STREET 1: C/O VISTERRA, INC. STREET 2: ONE KENDALL SQUARE, #B3301 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001819790 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 814717861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 409-9820 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 4 1 wf-form4_164392778280060.xml FORM 4 X0306 4 2022-02-01 0 0001819790 Tarsus Pharmaceuticals, Inc. TARS 0001661539 Trevejo Jose M. 15540 LAGUNA CANYON ROAD SUITE 160 IRVINE CA 92618 0 1 0 0 CHIEF MEDICAL OFFICER Employee Stock Option (right to buy) 20.64 2022-02-01 4 A 0 116424 0 A 2032-01-31 Common Stock 116424.0 116424 D Restricted Stock Units 2022-02-01 4 A 0 30197 0 A Common Stock 30197.0 30197 D 25% of the option shares shall vest on February 1, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. /s/ Leonard M. Greenstein 2022-02-03